»
NEWS » Oncolytic effects of the recombinant Newcastle disease virus, rAF-IL12, against colon cancer cells in vitro and in tumor-challenged NCr-Foxn1nu nude mice - Prof. Dr. Khatijah Yusoff and colleagues
Congratulations to Prof. Dr. Khatijah Yusoff and colleagues for their latest publication in PeerJ. This paper evaluates a combinatorial therapy between the recombinant Newcastle disease virus and interleukin-12 cytokine as a potential therapeutic vaccine to the current anti-cancer drugs for colon cancer. Find out more at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731658/
Date of Input: 10/03/2021 |
Updated: 10/03/2021 | azah
MEDIA SHARING
